Maas Biolab
Directory listingDirectory record status
These labels describe this UNITEMFG record. They do not guarantee current capabilities, certifications, capacity, quality, or fit for a specific job.
- Directory listing
- Listed
- Ownership
- Unclaimed
- Evidence reviewed
- Not recorded
- Last evidence review
- Not recorded
About
Maas Biolab is a specialized neuropharmaceutical company based in Albuquerque, New Mexico, dedicated to developing innovative treatments for chronic neurodegenerative diseases. The company focuses primarily on amyotrophic lateral sclerosis treatment development, utilizing cyclosporin as a neuroprotective agent through their proprietary Mitogard formula designed specifically for cerebrospinal fluid delivery. With operations spanning two New Mexico locations including Santa Fe headquarters and Albuquerque facilities, Maas Biolab has established itself as a pioneer in neuropharmaceutical manufacturing and research. The company holds significant intellectual property including formulation patents and production patents for cyclosporin applications in neuroprotection, supported by world patents for cyclosporin treatments against chronic neurological diseases including Alzheimer's, Parkinson's, and Huntington's disease. Maas Biolab has achieved notable regulatory recognition, receiving FDA Orphan Drug Designation for their cyclosporin ALS treatment, demonstrating the clinical potential of their research. The company leverages advanced laboratory equipment including Sony SH800S Cell Sorter technology to support their pharmaceutical development processes. Their work has been supported through National Institutes of Health funding for pre-clinical stability, pharmacokinetics, and toxicology testing, underscoring their commitment to rigorous scientific validation and regulatory compliance in developing life-changing treatments for patients with devastating neurodegenerative conditions.